Glimepiride is a medium-to-long acting sulfonylurea anti-diabetic drug. It is marketed as Amaryl by Sanofi-Aventis and Glyree by Ipca. Glimepiride is the first third-generation sulfonylurea, and is very potent.
Product Disclaimer :
The Seller / Buyer offers no guarantee that any claims of Patents, Drugs, Explosives, Narcotics, or
any other outlawed by Government Authorities that cover the use or Sale / Purchase of the products listed above won't be violated, and it's the Buyer's / Seller's risk and liability.
CHEMICALS BY ALPHABET